Literature DB >> 24723723

Genome Sequence of Burkholderia cenocepacia H111, a Cystic Fibrosis Airway Isolate.

Aurelien Carlier1, Kirsty Agnoli, Gabriella Pessi, Angela Suppiger, Christian Jenul, Nadine Schmid, Burkhard Tümmler, Marta Pinto-Carbo, Leo Eberl.   

Abstract

The Burkholderia cepacia complex (BCC) is a group of related bacterial species that are commonly isolated from environmental samples. Members of the BCC can cause respiratory infections in cystic fibrosis patients and immunocompromised individuals. We report here the genome sequence of Burkholderia cenocepacia H111, a well-studied model strain of the BCC.

Entities:  

Year:  2014        PMID: 24723723      PMCID: PMC3983312          DOI: 10.1128/genomeA.00298-14

Source DB:  PubMed          Journal:  Genome Announc


GENOME ANNOUNCEMENT

The Burkholderia cepacia complex (BCC) is a group of 18 closely related bacterial species, which can cause life-threatening disease in immunocompromised and cystic fibrosis (CF) patients (1, 2). BCC species are commonly found in soil or associated with plants (3–5). Burkholderia cenocepacia H111 is a member of the BCC that was isolated from a sputum sample from a CF patient (6). While closely related, B. cenocepacia H111 does not belong to the epidemic ET12 lineage, from which three genomes (strains J2315, BC7, and K56-2) have been sequenced (7, 8). Strains of the ET12 lineage are highly transmissible and have resulted in high mortality among infected CF patients (9, 10). In contrast, the CF patient infected with B. cenocepacia H111 did not show acute symptoms. The infection cleared after a 6-month coinfection period with Pseudomonas aeruginosa (6). B. cenocepacia H111 is sensitive to several antibiotics, is easily amenable to genetic manipulation, and its physiology and virulence in various infection models are well studied (11–16). Together, these properties make its genome a valuable addition to the growing number of sequenced BCC genomes. Genomic DNA was prepared according to Wilson (17). A combination of Roche 454 GS-FLX Titanium 3-kb-span paired-end libraries (~25× coverage), Roche 454 GS-GLX Titanium fragment reads (~25× coverage), and Illumina 36-bp fragments (50× coverage) were assembled into 71 contigs using the CLC Genomics Workbench version 5.0 software (CLC bio, Aarhus, Denmark). To fill the small gaps in the assembly that were probably caused by ambiguities in G+C-rich regions of the genome, we sequenced a large-insert library (8 to 12 kb) using the PacBio RS II kit to approximately 30× coverage (Pacific Biosciences, Menlo Park, CA, USA). We used the AHA algorithm from the SMRT Portal (Pacific Biosciences) to close all the gaps and generate high-quality circular consensus sequences of the 2 chromosomes and the megaplasmid pC3 that comprise the B. cenocepacia H111 genome. Chromosomes 1 and 2 in H111 have sizes of 3.57 Mb and 3.10 Mb, respectively, and are slightly smaller than those of the closely related B. cenocepacia J2315 strain (3.83 Mb and 3.19 Mb, respectively) (8). Several large genomic islands are missing from chromosome 1 of H111 (e.g., BcenGI5, BcenGI6, and BenGI8 with sizes of 92 kb, 34 kb, and 121 kb, respectively), accounting for the smaller size. A 102-kb region that contains the B. cenocepacia pathogenicity island cci (18), the type IV secretion system genomic island (8), and the low-oxygen-activated locus lxa (19) is absent from chromosome 2 of B. cenocepacia H111. Conversely, the facultative pC3 replicon is larger than that of B. cenocepacia J2315 at 1.04 Mb versus 0.88 Mb. The pC3 replicon codes for specific traits, such as virulence and stress resistance, and is less conserved among BCC members than chromosomes 1 and 2 (20, 21). The genome was annotated using the RAST pipeline (22). The results of the automated annotation were augmented and curated using the Artemis software package (23). The genome contains 6,933 open reading frames, which is comparable to the gene content of other B. cenocepacia genomes.

Nucleotide sequence accession numbers.

The sequences of the three replicons of B. cenocepacia H111 have been deposited at DDBJ/EMBL/GenBank under the accession no. HG938370, HG938371, and HG938372.
  23 in total

1.  Genetic analysis of functions involved in the late stages of biofilm development in Burkholderia cepacia H111.

Authors:  Birgit Huber; Kathrin Riedel; Manuela Köthe; Michael Givskov; Søren Molin; Leo Eberl
Journal:  Mol Microbiol       Date:  2002-10       Impact factor: 3.501

Review 2.  Classification and identification of the Burkholderia cepacia complex: Past, present and future.

Authors:  Peter Vandamme; Peter Dawyndt
Journal:  Syst Appl Microbiol       Date:  2011-01-22       Impact factor: 4.022

Review 3.  Common features of environmental and potentially beneficial plant-associated Burkholderia.

Authors:  Zulma Rocío Suárez-Moreno; Jesús Caballero-Mellado; Bruna G Coutinho; Lucia Mendonça-Previato; Euan K James; Vittorio Venturi
Journal:  Microb Ecol       Date:  2011-08-18       Impact factor: 4.552

4.  Identification of a novel virulence factor in Burkholderia cenocepacia H111 required for efficient slow killing of Caenorhabditis elegans.

Authors:  Birgit Huber; Friederike Feldmann; Manuela Köthe; Peter Vandamme; Julia Wopperer; Kathrin Riedel; Leo Eberl
Journal:  Infect Immun       Date:  2004-12       Impact factor: 3.441

5.  Identification of Burkholderia cenocepacia strain H111 virulence factors using nonmammalian infection hosts.

Authors:  Stephan Schwager; Kirsty Agnoli; Manuela Köthe; Friederike Feldmann; Michael Givskov; Aurelien Carlier; Leo Eberl
Journal:  Infect Immun       Date:  2012-10-22       Impact factor: 3.441

6.  Burkholderia pseudomultivorans sp. nov., a novel Burkholderia cepacia complex species from human respiratory samples and the rhizosphere.

Authors:  Charlotte Peeters; James E A Zlosnik; Theodore Spilker; Trevor J Hird; John J LiPuma; Peter Vandamme
Journal:  Syst Appl Microbiol       Date:  2013-07-16       Impact factor: 4.022

7.  Production of N-acyl-L-homoserine lactones by P. aeruginosa isolates from chronic lung infections associated with cystic fibrosis.

Authors:  O Geisenberger; M Givskov; K Riedel; N Høiby; B Tümmler; L Eberl
Journal:  FEMS Microbiol Lett       Date:  2000-03-15       Impact factor: 2.742

8.  Epidemiology of Burkholderia cepacia complex in patients with cystic fibrosis, Canada.

Authors:  David P Speert; Deborah Henry; Peter Vandamme; Mary Corey; Eshwar Mahenthiralingam
Journal:  Emerg Infect Dis       Date:  2002-02       Impact factor: 6.883

9.  The unexpected discovery of a novel low-oxygen-activated locus for the anoxic persistence of Burkholderia cenocepacia.

Authors:  Andrea M Sass; Crystal Schmerk; Kirsty Agnoli; Phillip J Norville; Leo Eberl; Miguel A Valvano; Eshwar Mahenthiralingam
Journal:  ISME J       Date:  2013-03-14       Impact factor: 10.302

10.  Response of Burkholderia cenocepacia H111 to micro-oxia.

Authors:  Gabriella Pessi; Rubina Braunwalder; Alexander Grunau; Ulrich Omasits; Christian H Ahrens; Leo Eberl
Journal:  PLoS One       Date:  2013-09-02       Impact factor: 3.240

View more
  20 in total

1.  σ54-Dependent Response to Nitrogen Limitation and Virulence in Burkholderia cenocepacia Strain H111.

Authors:  Martina Lardi; Claudio Aguilar; Alessandro Pedrioli; Ulrich Omasits; Angela Suppiger; Gerardo Cárcamo-Oyarce; Nadine Schmid; Christian H Ahrens; Leo Eberl; Gabriella Pessi
Journal:  Appl Environ Microbiol       Date:  2015-04-03       Impact factor: 4.792

2.  Molecular mechanisms underlying the close association between soil Burkholderia and fungi.

Authors:  Nejc Stopnisek; Daniela Zühlke; Aurélien Carlier; Albert Barberán; Noah Fierer; Dörte Becher; Katharina Riedel; Leo Eberl; Laure Weisskopf
Journal:  ISME J       Date:  2015-05-19       Impact factor: 10.302

3.  Immune Recognition of the Epidemic Cystic Fibrosis Pathogen Burkholderia dolosa.

Authors:  Damien Roux; Molly Weatherholt; Bradley Clark; Mihaela Gadjeva; Diane Renaud; David Scott; David Skurnik; Gregory P Priebe; Gerald Pier; Craig Gerard; Deborah R Yoder-Himes
Journal:  Infect Immun       Date:  2017-05-23       Impact factor: 3.441

4.  The Essential Genome of Burkholderia cenocepacia H111.

Authors:  Steven Higgins; Maria Sanchez-Contreras; Stefano Gualdi; Marta Pinto-Carbó; Aurélien Carlier; Leo Eberl
Journal:  J Bacteriol       Date:  2017-10-17       Impact factor: 3.490

5.  Single amino acid substitution in homogentisate 1,2-dioxygenase is responsible for pigmentation in a subset of Burkholderia cepacia complex isolates.

Authors:  Laura A Gonyar; Sarah C Fankhauser; Joanna B Goldberg
Journal:  Environ Microbiol Rep       Date:  2014-12-17       Impact factor: 3.541

6.  In-Frame and Unmarked Gene Deletions in Burkholderia cenocepacia via an Allelic Exchange System Compatible with Gateway Technology.

Authors:  Mustafa Fazli; Joe J Harrison; Michela Gambino; Michael Givskov; Tim Tolker-Nielsen
Journal:  Appl Environ Microbiol       Date:  2015-03-20       Impact factor: 4.792

7.  Identification of Key Factors for Anoxic Survival of B. cenocepacia H111.

Authors:  Sarah Paszti; Alessandra Vitale; Yilei Liu; Rubina Braunwalder; Ratchara Kalawong; Olivier Biner; Gabriella Pessi; Leo Eberl
Journal:  Int J Mol Sci       Date:  2022-04-20       Impact factor: 6.208

8.  Cyanide Toxicity to Burkholderia cenocepacia Is Modulated by Polymicrobial Communities and Environmental Factors.

Authors:  Steve P Bernier; Matthew L Workentine; Xiang Li; Nathan A Magarvey; George A O'Toole; Michael G Surette
Journal:  Front Microbiol       Date:  2016-05-18       Impact factor: 5.640

Review 9.  Members of the genus Burkholderia: good and bad guys.

Authors:  Leo Eberl; Peter Vandamme
Journal:  F1000Res       Date:  2016-05-26

10.  Draft Genome Sequence of Burkholderia cenocepacia Strain CEIB S5-2, a Methyl Parathion- and p-Nitrophenol-Degrading Bacterium, Isolated from Agricultural Soils in Morelos, Mexico.

Authors:  Fernando Martínez-Ocampo; Maikel Gilberto Fernández López; Luis Fernando Lozano-Aguirre Beltrán; Elida Carolina Popoca-Ursino; M Laura Ortiz-Hernández; Enrique Sánchez-Salinas; Fernando Ramos Quintana; Miguel A Villalobos-López; Edgar Dantán-González
Journal:  Genome Announc       Date:  2016-04-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.